Goods and bads of the endocannabinoid system as a therapeutic target: Lessons learned after 30 years

M Maccarrone, V Di Marzo, J Gertsch, U Grether… - Pharmacological …, 2023 - ASPET
The cannabis derivative marijuana is the most widely used recreational drug in the Western
world and is consumed by an estimated 83 million individuals (∼ 3% of the world …

CB2: a cannabinoid receptor with an identity crisis

BK Atwood, K Mackie - British journal of pharmacology, 2010 - Wiley Online Library
CB2 was first considered to be the 'peripheral cannabinoid receptor'. This title was bestowed
based on its abundant expression in the immune system and presumed absence from the …

Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐HT1A receptors without diminishing nervous system function or chemotherapy efficacy

SJ Ward, SD McAllister, R Kawamura… - British journal of …, 2014 - Wiley Online Library
Background and Purpose Paclitaxel (PAC) is associated with chemotherapy‐induced
neuropathic pain (CIPN) that can lead to the cessation of treatment in cancer patients even …

An overview of the cannabinoid type 2 receptor system and its therapeutic potential

B Bie, J Wu, JF Foss, M Naguib - Current Opinion in …, 2018 - journals.lww.com
An overview of the cannabinoid type 2 receptor system and it... : Current Opinion in
Anesthesiology An overview of the cannabinoid type 2 receptor system and its therapeutic …

[HTML][HTML] Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside

EJ Rahn, AG Hohmann - Neurotherapeutics, 2009 - Elsevier
Neuropathic pain is a debilitating form of chronic pain resulting from nerve injury, disease
states, or toxic insults. Neuropathic pain is often refractory to conventional …

The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia

LR Watkins, MR Hutchinson, KC Rice… - Trends in pharmacological …, 2009 - cell.com
Glial activation participates in the mediation of pain including neuropathic pain, due to
release of neuroexcitatory, proinflammatory products. Glial activation is now known to occur …

Endogenous opiates and behavior: 2005

RJ Bodnar, GE Klein - Peptides, 2006 - Elsevier
This paper is the 28th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning over a quarter-century of research. It …

Ruthenium (II)‐Catalyzed Asymmetric Inert C− H Bond Activation Assisted by a Chiral Transient Directing Group

G Li, Q Liu, L Vasamsetty, W Guo… - Angewandte Chemie …, 2020 - Wiley Online Library
A ruthenium (II)‐catalyzed asymmetric intramolecular hydroarylation assisted by a chiral
transient directing group has been developed. A series of 2, 3‐dihydrobenzofurans bearing …

Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1–dependent withdrawal

L Deng, J Guindon, BL Cornett, A Makriyannis… - Biological …, 2015 - Elsevier
Background Mixed cannabinoid receptor 1 and 2 (CB 1 and CB 2) agonists such as Δ 9-
tetrahydrocannabinol (Δ 9-THC) can produce tolerance, physical withdrawal, and unwanted …

Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

SM Brierley, B Greenwood-Van Meerveld… - Nature Reviews …, 2023 - nature.com
The management of visceral pain in patients with disorders of gut–brain interaction, notably
irritable bowel syndrome, presents a considerable clinical challenge, with few available …